There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Direct antiviral therapies for chronic hepatitis C virus (HCV) infection have expanded
treatment options for neglected patient populations, including elderly patients who
are ineligible/intolerant to receive interferon (IFN)-based therapy.